1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Patrys Limited
  6. News
  7. Summary
    PAB   AU000000PAB9

PATRYS LIMITED

(PAB)
Delayed Australian Stock Exchange  -  02:10 2022-06-28 am EDT
0.0200 AUD   -9.09%
06/14Patrys Identifies New Mechanism of Action for Anti-Cancer Antibody
MT
06/03Patrys Secures Grant Funding to Develop Brain Cancer Drug
MT
04/27PATRYS : Appendix 4C - Quarterly - 31 March 2022
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Patrys : Application for quotation of securities - PAB

12/05/2021 | 05:52pm EDT

Application for quotation of +securities

Announcement Summary

For personal use only

Entity name

PATRYS LIMITED

Announcement Type

New announcement

Date of this announcement

Monday December 06, 2021

The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

Total number of +securities to be quoted

ASX +security

Number of +securities to

code

Security description

be quoted

Issue date

PAB

ORDINARY FULLY PAID

128,070,116

06/12/2021

Refer to next page for full details of the announcement

Application for quotation of +securities

1 / 6

Application for quotation of +securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

PATRYS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2

Registered number type

Registration number

ABN

97123055363

1.3

ASX issuer code

PAB

  1. The announcement is New announcement
  2. Date of this announcement

6/12/2021

Application for quotation of +securities

2 / 6

Application for quotation of +securities

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

For personal use only

Previous Appendix 3B details:

Announcement Date and

Announcement Title

Selected Appendix 3B to submit quotation

Time

request

01-Nov-2021 09:53

New - Proposed issue of securities -

A standard +pro rata issue (non-renounceable)

PAB

2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?

Yes

2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B

Issue of 24,314,474 shortfall shares in relation to the Rights Issue Offer. Proposed issue date 7 December 2021.

Application for quotation of +securities

3 / 6

Application for quotation of +securities

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

Corporate Action Component Detail

only

ASX +security code and description

PAB : ORDINARY FULLY PAID

Issue date

use

6/12/2021

Distribution Schedule

Provide a distribution schedule for the new +securities according to the categories set out in the left hand column -

including the number of recipients and the total percentage of the new +securities held by the recipients in each

category.

personalFor

Total percentage of +securities held

Number of +securities held

Number of holders

For example, to enter a value of 50%

please input as 50.00

1 - 1,000

%

1,001

- 5,000

%

5,001

- 10,000

%

10,001 - 100,000

%

100,001 and over

%

Application for quotation of +securities

4 / 6

Application for quotation of +securities

Issue details

Number of +securities to be quoted

128,070,116

For personal use only

Issue currency

Issue price or consideration per +security

AUD - Australian Dollar

AUD 0.03500000

Any other information the entity wishes to provide about the +securities to be quoted

Application for quotation of +securities

5 / 6

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Patrys Limited published this content on 05 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 December 2021 22:51:02 UTC.


© Publicnow 2021
All news about PATRYS LIMITED
06/14Patrys Identifies New Mechanism of Action for Anti-Cancer Antibody
MT
06/03Patrys Secures Grant Funding to Develop Brain Cancer Drug
MT
04/27PATRYS : Appendix 4C - Quarterly - 31 March 2022
PU
04/14PATRYS : Application for quotation of securities - PAB
PU
03/23NEW RESEARCH : Scientists determine structure of a DNA damage ‘First Responder' prot..
PU
02/27Patrys Limited Announces Stable Cell Line for Production of PAT-DX3
CI
02/24PATRYS : Appendix 4D - Half Year Accounts - 31 December 2021
PU
02/24Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2021
CI
02/07PATRYS : Application for quotation of securities - PAB
PU
02/07PATRYS : ADC Deals Making Headlines
PU
More news
Financials
Sales 2021 1,34 M 0,93 M 0,93 M
Net income 2021 -4,06 M -2,82 M -2,82 M
Net cash 2021 10,9 M 7,58 M 7,58 M
P/E ratio 2021 -22,2x
Yield 2021 -
Capitalization 41,1 M 28,6 M 28,6 M
EV / Sales 2020 11,5x
EV / Sales 2021 67,8x
Nbr of Employees 10
Free-Float 70,9%
Chart PATRYS LIMITED
Duration : Period :
Patrys Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PATRYS LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
James A. Campbell Chief Executive Officer, MD & Director
John Douglas Read Non-Executive Chairman
Valentina Dubljevic Vice President-Scientific & Clinical Development
Michael J. Stork Deputy Chairman & Non-Executive Director
Suzy Jones Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
PATRYS LIMITED-40.54%31
MODERNA, INC.-43.20%57 385
IQVIA HOLDINGS INC.-24.22%40 468
LONZA GROUP AG-32.64%39 851
SEAGEN INC.16.00%33 010
CELLTRION, INC.-11.36%18 371